UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date
of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in its Charter)
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| ||
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s
telephone number, including area code:
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On June 20, 2022, Dr. Kunwar Shalubhai notified AccuStem Sciences Inc. (the “Company”) of his decision to resign as a member of the Board, effective immediately. Dr. Shailubhai’s resignation was not a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
-2- |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ACCUSTEM SCIENCES INC. | ||
Date: June 21, 2022 | By: | /s/ Wendy Blosser |
Wendy Blosser Chief Executive Officer |
-3- |
Cover |
Jun. 20, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jun. 20, 2022 |
Entity File Number | 000-56257 |
Entity Registrant Name | AccuStem Sciences Inc. |
Entity Central Index Key | 0001850767 |
Entity Tax Identification Number | 87-3774438 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 5 Penn Plaza, 19th Floor |
Entity Address, Address Line Two | #1954 |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10001 |
City Area Code | 00 44 |
Local Phone Number | 2074952379 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |
-8?20$3;8T.P6BP^0"X99K>]
M9!:G
)OU8X(V++?P%02P,$% @ 3G35
M5)9,[N!6!P U5< !4 !A8W5T+3(P,C(P-C(P7W!R92YX;6S-G%U3VS@4
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M%*%+8W JQ;DUD,]B
MQ2/'QN8LOG@'#Z@!/OP1C!+6H3^)1R",I!;_^U=Z+W5XE%0AU!'CPH==?'N6
M J0SZ^6U:Y!X$W?ELCZ[9 VISGN"H-3?L5"#:C&8&@_5B8&U/LH"S8YE4#W,
MO"##!P[(\.#3B5S0(S81C9AF_]\9\I(A^C9*,$'@42O)1*DH#E=$_+Y/_$VC
MWJZ<;F^UVJ5VI;6F3+0JY9OK>KM>:6UOE1JGJ/*E?%9JU"JH?'EQ46^UZI>-
M->-,\3F[+;7.ZHU:^[*QN[UUFB@GD)+*90_6C!MI*8&9K!?5\_0^Q<7Z'L<@
M'> (N]R:."%&N[W)LV=XXAG/.N^+W\;3OJW,U]RG5B^O+X!2.:0()<4^]2"5
ME]OO>/S4TERQFQ*)CSMMDBF8Y@Q^-GNWV<_5;[1>ASWEO]Z^S>*+%??C'^?W
M;A,)KY6P-SYEXU-^?TU1BQ#97%<:[>VMZTKS\KJ]CE8*7#1=YKC8Y-M;W (X
M363G43J#+(;2N1W]PYJR976 H1X1'+F,<@K]*R.MATVPC)+&D=5!Z8-,=AVY
M6UN#$4FL[2V0/".VQ3C:$0_$3!#,#)@ACL@]X/6;B?ZA@.:7ZI.YI;HI4V 5
M+T$6O69KM'F9Y>3+N*2_>,WVSJV.8W3$"SI@&D"_GH['8Z"=N?SN-Q* W4WF?A&WI >2APE
MUZLWBDM^J'5&U4OY5Y2"1@$E[8.:;GJ
YUX^HOOR?FH
M^OTF]7'XO735NTE>70Y'W^B>.OIV4#.N;VZ=>O]+155/VF45?[OH#]B98Z@U
MX[[R];;T-7-_3RI*O=]@5TJU?:X99K]VOC=66Z9;.:OP/J]J%]_-5KXU/M7.
M:LD:T=7;@W_VF^UR?U@[_YZ[/,_;]6;[]N?WKE.QRY_H5\ML6=6;\>=V66O]
M0UENK_7I1CE)][C>5;]6S\[[N.%VT_=97.EG]EIVAWW^G%.NS59-O3H=WW:3
M,.SM1?7D'Y;J)K^[]0O>JGS-[%&M5?MQJ_S3P)F?GR\N?PR_VRGWZNQ 35Z=
M5&NC\ZOA\;$GDO\#4$L! A0#% @ 3G355#&)X[XJ P JPL !$
M ( ! &%C=70M,C R,C V,C N>'-D4$L! A0#% @ 3G35
M5'*4Y-[^"@ @(8 !4 ( !60, &%C=70M,C R,C V,C!?
M;&%B+GAM;%!+ 0(4 Q0 ( $YTU5263.[@5@< -57 5
M " 8H. !A8W5T+3(P,C(P-C(P7W!R92YX;6Q02P$"% ,4 " !.=-54
M/[1KL# 1 #DA0 "P @ $3%@ 9F]R;3@M:RYH=&U02P4&
2 0 ! #^ ;"<
end